The People's Pharmacy · Joe and Terry Graedon

Show 1441: How Exercise Can Help Cancer Patients Survive & Thrive

August 15, 2025·1 hr 1 min·5 clips
Exercise reduced colorectal cancer recurrence by 28% and death risk by 37% in a landmark clinical trial.
The episode opens with health news. One item points to a JAMA Network Open study suggesting that physician industry payments are linked to a higher likelihood of patient complaints. The main conversation then shifts to exercise and colorectal cancer. Terry and Joe put the question plainly: can movement help cancer patients survive and thrive? They note that colorectal cancer is the fourth leading cause of cancer related death in the U.S. Dr. Christopher Booth answers with a mechanism based explanation, saying exercise triggers physiologic, hormonal, inflammatory, and immunologic changes that may help the body eradicate a proportion of cancer cells. He brings that idea into a clinical setting through research on a personalized physical activity program added to colorectal cancer treatment. The discussion centers on a randomized trial with disease free survival as the primary endpoint. That endpoint included death, recurrent disease, or a new cancer. Booth says the exercise arm showed a substantial drop in risk. The risk of recurrent or new cancer fell by 28 percent. At five years, 74 percent of patients in the control group were alive and free of cancer, compared with 80 percent in the exercise group. That difference works out to an absolute benefit of 6 percent. Put another way, one recurrence or new cancer was prevented for every 16 patients who followed the exercise program. The hosts press him on how that compares with chemotherapy. Booth says the effect size is comparable to many standard, very good chemotherapy drugs. He also points out an important difference: unlike drug therapy, exercise brings other benefits to everyone who does it, even when it does not prevent recurrence. The main safety signal was a modest increase in musculoskeletal injuries. The segment lands on a simple point: exercise is not a cure all, but it does look like a practical, evidence backed part of cancer care.

As heard by us

Exercise is framed as cancer care, with trial data and a clear limit on the claim.

The episode treats exercise as part of cancer care, not as a wellness slogan, and it keeps that focus on colorectal cancer and Dr. Christopher Booth's personalized physical-activity program.

Read the full review in PlayNext →

Why you'd press play

You want a plainspoken case for exercise as part of colorectal cancer care.

Read the full recommendation in PlayNext →
Listen to the show on